Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 2171-2176, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, I. E.A.
Right arrow Articles by De Keyser, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, I. E.A.
Right arrow Articles by De Keyser, F.
Related Collections
Right arrow Clinical Immunology
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2002;48:2171-2176.)
© 2002 American Association for Clinical Chemistry, Inc.

Detection of Specific Antinuclear Reactivities in Patients with Negative Anti-nuclear Antibody Immunofluorescence Screening Tests

Ilse E.A. Hoffman1a, Isabelle Peene1, Eric M. Veys1 and Filip De Keyser1

1 Department of Rheumatology, Ghent University Hospital, De Pintelaan 185, Ghent 9000, Belgium.

aAuthor for correspondence. Fax 32-9-240-38-03; e-mail Ilse.Hoffman{at}rug.ac.be.

Background: For detection of anti-nuclear antibodies (ANAs) and antibodies to extractable nuclear antigens (ENAs), samples frequently are screened with indirect immunofluorescence (IIF); further determination of anti-ENA antibodies is performed only when the result is positive. However, because anti-ENA reactivities are found in samples with low fluorescence intensities, we determined anti-ENA antibodies in samples with negative IIF and thus calculated the sensitivity of IIF for specific ANAs.

Methods: We collected 494 samples consecutively referred by rheumatologists for routine ANA testing. IIF on HEp-2 and HEp-2000 (HEp-2 cells transfected with Ro60 cDNA) and line immunoassay (LIA) for the detection of specific ANAs were performed on all samples.

Results: Fluorescence intensities and patterns on HEp-2 were strongly correlated with those on HEp-2000 [Spearman {rho} = 0.852 (P <0.001) and 0.838 (P <0.001), respectively]. Sixty-eight of 494 samples were positive on LIA, of which only 72% (confidence interval, 68–76%) were detected with HEp-2 and 75% (confidence interval, 70–78%) with HEp-2000. Of 291 samples negative on both substrates, 12 were positive on LIA. Connective tissue diseases were diagnosed in four of these patients and suspected in at least three others.

Conclusion: The HEp-2 and HEp-2000 substrates perform comparably for fluorescence intensities and patterns and for detecting specific ANAs, but some patients with negative IIF show reactivity on LIA. We recommend testing for fine reactivities, regardless of the IIF result, when the clinical suspicion for rheumatic connective tissue disease is high.




The following articles in journals at HighWire Press have cited this article:


Home page
LupusHome page
S. Binder
Autoantibody Detection Using Multiplex Technologies
Lupus, July 1, 2006; 15(7): 412 - 421.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
P. A. J. M. Vos, E. J. E. G. Bast, and R. H. W. M. Derksen
Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice
Rheumatology, May 1, 2006; 45(5): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. R. Binder, M. C. Genovese, J. T. Merrill, R. I. Morris, and A. L. Metzger
Computer-Assisted Pattern Recognition of Autoantibody Results
Clin. Vaccine Immunol., December 1, 2005; 12(12): 1353 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Bossuyt and A. Luyckx
Antibodies to Extractable Nuclear Antigens in Antinuclear Antibody-Negative Samples
Clin. Chem., December 1, 2005; 51(12): 2426 - 2427.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.